Elevated levels of B. fragilis-derived LPS have been found in the hippocampus and neocortex of AD patients (42) as well as overexpression of microglial TLR2, TLR4, and LPS receptor CD14 in both AD patients and AD-like mice models (48, 49). Here, TLR4 is linked to Alzheimer disease.